垂体神经内分泌肿瘤诊断与影像随访建议
西班牙内分泌与营养学会(SEEN)神经内分泌领域牵头制定多学科文件,聚焦垂体神经内分泌肿瘤(PitNETs)诊断、预后及随访中的神经影像检查。文件描述了MRI应涵盖的基本要求和要素,并提出便于临床治疗决策的最低限度放射学报告。该文件补充了SEEN与西班牙病理学会(SEAP)关于PitNETs病理研究的共识。
要点
- MRI是PitNETs诊断、预后和随访的核心神经影像手段。
- 文件提出MRI应涵盖的基本要素及最低限度放射学报告框架。
- 放射学报告需服务于临床治疗决策,规范报告内容。
核心结论
- SEEN神经内分泌领域发布多学科文件,更新PitNETs诊断、术前术后管理及治疗反应随访的指南,重点聚焦神经影像在诊断、预后和随访中的作用。
研究设计与样本
- 该文件由西班牙内分泌与营养学会(SEEN)神经内分泌领域发起,为多学科共识性建议文件。
- 文件聚焦神经影像研究,描述MRI应涵盖的基本要求和要素,并提出最低限度放射学报告。
- 文件补充SEEN与西班牙病理学会(SEAP)关于PitNETs病理研究的共识。
临床应用与阅片要点
- 日常阅片应按文件描述的MRI基本要求和要素进行,确保覆盖诊断、预后及随访所需信息。
- 放射学报告应采用文件提出的最低限度报告框架,以辅助临床治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pituitary neuroendocrine tumours (PitNETs) constitute a heterogeneous group of tumours with a gradually increasing incidence, partly accounted for by more sensitive imaging techniques and more extensive experience in neuroradiology in this regard. Although most PitNETs are indolent, some exhibit aggressive behaviour, and recurrence may be seen after surgical removal. The changes introduced in the WHO classification in 2017 and terminological debates in relation to neuroendocrine tumours warrant an update of the guidelines for the diagnosis, preoperative and postoperative management, and follow-up of response to treatment of PitNETs. This multidisciplinary document, an initiative of the Neuroendocrinology area of the Sociedad Española de Endocrinología y Nutrición [Spanish Society of Endocrinology and Nutrition] (SEEN), focuses on neuroimaging studies for the diagnosis, prognosis and follow-up of PitNETs. The basic requirements and elements that should be covered by magnetic resonance imaging are described, and a minimum radiology report to aid clinicians in treatment decision-making is proposed. This work supplements the consensus between the Neuroendocrinology area of the SEEN and the Sociedad Española de Anatomía Patológica [Spanish Society of Pathology] (SEAP) for the pathological study of PitNETs.
引用
- Fajardo-Montañana, Villar, Gómez-Ansón, et al. Recommendations for the diagnosis and radiological follow-up of pituitary neuroendocrine tumours. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 36428207. doi:10.1016/j.endien.2021.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。